K2 Principal Fund’s BioTelemetry, Inc. BEAT Stock Holding History

K2 Principal Fund’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,054	Closed	-$220K	–	501
2020 Q4	$220K	Buy	+3,054	New	+$160K	0.02%	274

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

K2 Principal Fund's BEAT Position: Q1 2021 in Review

K2 Principal Fund sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,054 shares — an estimated $220K sold.

K2 Principal Fund first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $220K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

K2 Principal Fund reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
K2 Principal Fund sold 3,054 BioTelemetry, Inc. shares in Q1 2021, an estimated $220K.
K2 Principal Fund first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
K2 Principal Fund's BioTelemetry, Inc. position peaked at $220K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on K2 Principal Fund's 13F filing for Q1 2021, filed 14 May 2021.